Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan G Moore

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Expert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
Practical approach for using Medicare data to estimate costs for cost-effectiveness analysisJohn W Tumeh, Susan G Moore, Rachel Shapiro, et al.
American Journal of Clinical Oncology|February 6, 2009
A Markov model assessing the effectiveness and cost-effectiveness of FOLFOX compared with FOLFIRI for the initial treatment of metastatic colorectal cancerJohn W Tumeh, Pareen J Shenoy, Susan G Moore, et al.
BMC Health Services Research|January 16, 2009
Cost-effectiveness of MRI compared to mammography for breast cancer screening in a high risk populationSusan G Moore, Pareen J Shenoy, Laura Fanucchi, et al.
Cancer Informatics|May 21, 2009
Development of query strategies to identify a histologic lymphoma subtype in a large linked database systemMichael Graiser, Susan G Moore, Rochelle Victor, et al.
The Oncologist|March 14, 2015
Geriatric assessment-identified deficits in older cancer patients with normal performance statusTrevor A Jolly, Allison M Deal, Kirsten A Nyrop, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2011
Genotype-guided tamoxifen dosing increases active metabolite exposure in women with reduced CYP2D6 metabolism: a multicenter studyWilliam J Irvin, Christine M Walko, Karen E Weck, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Expert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
Practical approach for using Medicare data to estimate costs for cost-effectiveness analysisJohn W Tumeh, Susan G Moore, Rachel Shapiro, et al.
American Journal of Clinical Oncology|February 6, 2009
A Markov model assessing the effectiveness and cost-effectiveness of FOLFOX compared with FOLFIRI for the initial treatment of metastatic colorectal cancerJohn W Tumeh, Pareen J Shenoy, Susan G Moore, et al.
BMC Health Services Research|January 16, 2009
Cost-effectiveness of MRI compared to mammography for breast cancer screening in a high risk populationSusan G Moore, Pareen J Shenoy, Laura Fanucchi, et al.
Cancer Informatics|May 21, 2009
Development of query strategies to identify a histologic lymphoma subtype in a large linked database systemMichael Graiser, Susan G Moore, Rochelle Victor, et al.
The Oncologist|March 14, 2015
Geriatric assessment-identified deficits in older cancer patients with normal performance statusTrevor A Jolly, Allison M Deal, Kirsten A Nyrop, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2011
Genotype-guided tamoxifen dosing increases active metabolite exposure in women with reduced CYP2D6 metabolism: a multicenter studyWilliam J Irvin, Christine M Walko, Karen E Weck, et al.
Pageof 1